Fonte: Abstracts. Nome do evento: Mesenchymal Stem Cells: toward cell therapy for Immune-mediated disorders. Unidade: FMRP
Assuntos: IMUNOSSUPRESSÃO, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MALMEGRIM, K. C. R. et al. Isolation and characterization of multipotent mesenchymal stromal cells derived from bone marrow of type 1 diabetes and multiple sclerosis patients before and after exposure to high-dose immunossupression. 2007, Anais.. Genova: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2007. . Acesso em: 21 ago. 2024.APA
Malmegrim, K. C. R., Prata, K. L., Silva, A. C. G., Bolzoni, R. M. F., Palma P. B. V.,, Solano, K., et al. (2007). Isolation and characterization of multipotent mesenchymal stromal cells derived from bone marrow of type 1 diabetes and multiple sclerosis patients before and after exposure to high-dose immunossupression. In Abstracts. Genova: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Malmegrim KCR, Prata KL, Silva ACG, Bolzoni RMF, Palma P. B. V., Solano K, Orellana MD, Zago MA, Covas DT, Voltarelli JC. Isolation and characterization of multipotent mesenchymal stromal cells derived from bone marrow of type 1 diabetes and multiple sclerosis patients before and after exposure to high-dose immunossupression. Abstracts. 2007 ;[citado 2024 ago. 21 ]Vancouver
Malmegrim KCR, Prata KL, Silva ACG, Bolzoni RMF, Palma P. B. V., Solano K, Orellana MD, Zago MA, Covas DT, Voltarelli JC. Isolation and characterization of multipotent mesenchymal stromal cells derived from bone marrow of type 1 diabetes and multiple sclerosis patients before and after exposure to high-dose immunossupression. Abstracts. 2007 ;[citado 2024 ago. 21 ]